{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:10:20Z","timestamp":1788891020286,"version":"build-2803163510"},"reference-count":22,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Familial hypocalciuric hypercalcaemia (FHH) is a rare, benign genetic disorder of calcium homeostasis caused by inactivating variants in CaSR, GNA11, or AP2S1 genes. It is typically characterised by mild, asymptomatic hypercalcaemia and low urinary calcium excretion. Differentiation from primary hyperparathyroidism (PHPT) is essential, as misdiagnosis can lead to unnecessary surgery. We report a case of FHH type 1 (FHH1) in a man in his thirties presenting with a serum calcium level of 2.97 mmol\/L, which is at the severe end of the FHH spectrum. Genetic testing revealed a heterozygous CaSR nonsense variant (NM_000388.4:c.1942C&amp;gt;T, p.Arg648Ter) consistent with FHH1. The patient had clinically stable hypercalcaemia, which was not treated. During follow-up, he developed gallstones treated with a laparoscopic cholecystectomy. A review of the literature demonstrated that calcium levels approaching 3 mmol\/L, although uncommon, have been reported in other cases of FHH1. We review the literature regarding a potential association between FHH and gallstones. This case highlights that FHH can present with relatively marked hypercalcaemia, reinforcing the need for genetic evaluation before surgery, and suggests a possible but under-explored relationship between FHH and gallstone disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1530\/edm-26-0022","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:51:51Z","timestamp":1788889911000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["Significantly elevated calcium levels and gallstone disease in a patient with familial hypocalciuric hypercalcaemia"],"prefix":"10.1530","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0878-0182","authenticated-orcid":true,"given":"Adam","family":"Sabo","sequence":"first","affiliation":[{"name":"North Devon District Hospital 1 , ,","place":["Barnstaple, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6833-9399","authenticated-orcid":true,"given":"Andrew","family":"McGovern","sequence":"additional","affiliation":[{"name":"University of Exeter Institute of Biomedical and Clinical Science 2 , ,","place":["Exeter, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026090813514697300_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026090813514697300_bib3","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/jc.2007-0123","article-title":"Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status","volume":"92","author":"Zajickova","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090813514697300_bib4","article-title":"Familial hypocalciuric hypercalcemia","volume-title":"StatPearls","author":"Nava Suarez","year":"2025"},{"key":"2026090813514697300_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1752-1947-5-564","article-title":"Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series","volume":"5","author":"Rasmussen","year":"2011","journal-title":"J Med Case Rep"},{"key":"2026090813514697300_bib6","article-title":"Cinacalcet in familial hypocalciuric hypercalcaemia: friend or foe?","volume":"109","author":"Radia","journal-title":"Endocrine Abstracts"},{"key":"2026090813514697300_bib7","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090813514697300_bib8","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype\u2013phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2026090813514697300_bib9","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2007-0322","article-title":"Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population","volume":"92","author":"Nissen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090813514697300_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12020-017-1241-5","article-title":"Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia","volume":"55","author":"Szalat","year":"2017","journal-title":"Endocrine"},{"key":"2026090813514697300_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","article-title":"Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population","volume":"106","author":"Dershem","year":"2020","journal-title":"Am J Hum Genet"},{"key":"2026090813514697300_bib12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin Endocrinol"},{"key":"2026090813514697300_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2265.2006.02512.x","article-title":"Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia","volume":"64","author":"Ward","year":"2006","journal-title":"Clin Endocrinol"},{"key":"2026090813514697300_bib15","first-page":"13","article-title":"A novel mutation in the calcium-sensing receptor gene in a Chinese subject with persistent hypercalcemia and hypocalciuria","volume":"86","author":"Jap","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090813514697300_bib16","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1359\/jbmr.2002.17.12.2174","article-title":"Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene","volume":"17","author":"Yamauchi","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2026090813514697300_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-102-4-511","article-title":"Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families","volume":"102","author":"Law","year":"1985","journal-title":"Ann Intern Med"},{"key":"2026090813514697300_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-8529(18)30362-1","article-title":"Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism","volume":"18","author":"Heath","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026090813514697300_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: cholelithiasis and cancer","volume":"6","author":"Stinton","year":"2012","journal-title":"Gut Liver"},{"key":"2026090813514697300_bib20","doi-asserted-by":"crossref","first-page":"G528","DOI":"10.1152\/ajpgi.00387.2010","article-title":"Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor","volume":"300","author":"Wang","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026090813514697300_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jsfa.12918","article-title":"Identification and target of action of cholecystokinin-releasing peptides from simulated digestion hydrolysate of wheat protein","volume":"104","author":"Song","year":"2024","journal-title":"J Sci Food Agric"},{"key":"2026090813514697300_bib22","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.2174\/0929867324666170619104801","article-title":"Update on the molecular mechanisms underlying the effect of cholecystokinin and cholecystokinin-1 receptor on the formation of cholesterol gallstones","volume":"26","author":"Wang","year":"2019","journal-title":"Curr Med Chem"},{"key":"2026090813514697300_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0022-4804(81)90148-7","article-title":"Effects of cholecystokinin on gallbladder stasis and cholesterol gallstone formation","volume":"30","author":"Roslyn","year":"1981","journal-title":"J Surg Res"},{"key":"2026090813514697300_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.eprac.2023.12.002","article-title":"Risk of gallstone disease in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"30","author":"Pal","year":"2024","journal-title":"Endocr Pract"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.bioscientifica.com\/edm\/article-pdf\/doi\/10.1530\/EDM-26-0022\/525049\/edm-26-0022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/edm\/article-pdf\/doi\/10.1530\/EDM-26-0022\/525049\/edm-26-0022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:51:54Z","timestamp":1788889914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/edm\/article\/2026\/3\/EDM260022\/78172\/Significantly-elevated-calcium-levels-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1530\/edm-26-0022","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"EDM260022"}}